Mountain Pacific Investment Advisers LLC Trims Stake in Teleflex Incorporated $TFX

Mountain Pacific Investment Advisers LLC cut its position in Teleflex Incorporated (NYSE:TFX) by 25.3% in the second quarter, Holdings Channel reports. The firm owned 11,448 shares of the medical technology company’s stock after selling 3,879 shares during the period. Mountain Pacific Investment Advisers LLC’s holdings in Teleflex were worth $1,355,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 153 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its stake in Teleflex by 103.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 100 shares during the period. Banque Cantonale Vaudoise purchased a new position in Teleflex during the 1st quarter worth $27,000. Costello Asset Management INC acquired a new position in Teleflex in the first quarter valued at $28,000. Finally, Brooklyn Investment Group raised its holdings in shares of Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after buying an additional 150 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Insider Activity at Teleflex

In other news, CEO Liam Kelly acquired 1,500 shares of Teleflex stock in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average cost of $115.07 per share, with a total value of $172,605.00. Following the completion of the acquisition, the chief executive officer owned 45,267 shares in the company, valued at $5,208,873.69. This trade represents a 3.43% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Andrew A. Krakauer bought 1,000 shares of the firm’s stock in a transaction on Tuesday, August 5th. The shares were purchased at an average price of $115.25 per share, for a total transaction of $115,250.00. Following the completion of the transaction, the director owned 7,192 shares of the company’s stock, valued at $828,878. This represents a 16.15% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by company insiders.

Teleflex Trading Up 1.3%

Shares of TFX stock opened at $123.93 on Thursday. The business’s fifty day moving average price is $122.91 and its 200 day moving average price is $124.96. The firm has a market capitalization of $5.48 billion, a PE ratio of 29.16, a P/E/G ratio of 1.71 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $245.32.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. The company had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business’s revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the firm earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex’s dividend payout ratio (DPR) is 32.00%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Wells Fargo & Company dropped their price target on Teleflex from $137.00 to $131.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. Mizuho upped their price target on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, August 1st. Royal Bank Of Canada lifted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a research report on Friday, August 1st. Finally, Wall Street Zen cut shares of Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Teleflex presently has a consensus rating of “Hold” and an average target price of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.